Skip to content
Friday, November 6, 2026
London Super Center

Zimbabwe Rejects ‘One-Sided’ American Healthcare Assistance Deal Due to Information Fears

Health aid illustration
The offered US financial assistance was intended for programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

The nation of Zimbabwe has declined a significant US healthcare agreement worth $367m (£272m) spanning five years because of the United States' request for sensitive information.

The decision was revealed following a internal memorandum from December was disclosed, which showed Head of State Emmerson Mnangagwa felt the agreement was "lopsided".

A government spokesman later stated that the United States was requesting biological samples for research and commercial purposes while was not willing to share the benefits from future medical innovations.

"We must now begin the difficult and regrettable process of winding down our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the United States had furnished more than $1.9bn for health programmes to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has appealed for continued dialogue to find a deal suitable to both sides so the country's critical HIV treatment initiative can be sustained.

Wider Background

Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a high court blocked a similar deal with the US following concerns were filed about the security of citizens' health data.

After resuming the presidency last year, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).

USAID had administered aid for the US government, but Trump argued its expenditure was "wasteful" and his government was seeking direct bilateral deals to enhance openness and accountability.

According to reports, Sixteen nations in Africa have so far signed these new agreements, representing over $18.3bn in new funding.

Specifics of the Rejected Deal

This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".

"We are confident this cooperation would have delivered immense benefits for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy through American-funded initiatives," the Ambassador commented.

However, official spokesman Nick Mangwana said the proposed deal was "unfair".

"Our nation was requested to surrender its genetic material and health information indefinitely, with no equivalent promise of benefiting from any medical innovations – like new medicines or tests – that could be developed from that provided information," Mangwana explained.

"Effectively, our country would supply the raw materials for medical research without any assurance that the end products would be available to our citizens should a future disease outbreak arise."

National Interest and Global Health

He also said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting frameworks previously established through the international organization.

Mangwana gave as an example its Pandemic Benefit-Sharing system designed to manage future global health emergencies.

"This mechanism is designed to guarantee that when a country contributes its data, the benefits – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to develop them."

These objections over the US deal "are not meant as anti-American sentiment," Mangwana stressed.

"We encourage ongoing discussions with our American counterparts on how future co-operation might be arranged in a manner that honours the sovereignty and dignity of both nations."

Medical Community Response

Medical experts said it acknowledged the government's concerns, but recommended that negotiations need to persist since much of the country's Aids initiatives were funded by foreign aid.

"If technical issues arise, including those involving data governance or implementation frameworks, these can frequently be addressed via technical clarification and mutually agreed protections," the group added.

This impasse underscores the continuing debate between accepting crucial international aid and safeguarding national sovereignty in an increasingly interconnected world.

About the author

Benjamin Meyer

A travel writer and London enthusiast exploring the city's culture, history, and culinary scenes.

London Super Center

Type to search articles.